The Company respectfully advises the Staff that, for the reasons set forth below, the Company concludes that Rule 13e-3 would not be applicable to the Offer for the Securities with respect to either the Series E Depositary Shares or the Series D Depositary Shares.
An offeror’s obligation to comply with Rule 13e-3 arises from its engagement in a Rule 13e-3 transaction (or series of transactions) described in paragraph (a)(3)(i) of Rule 13e-3, which has a reasonable likelihood or a purpose of producing, either directly or indirectly, any of the following effects referred to in Rule
Rest of the answer
13e-3(a)(3)(ii):
(A) causing any class of equity securities of the issuer which is subject to section 12(g) or section 15(d) of the Exchange Act to become eligible for termination of registration under Exchange Act Rules 12g-4 or 12h-6 or causing the reporting obligations with respect to such class to become eligible for termination under Exchange Act Rule 12h-6; or suspension under Exchange Act Rule 12h-3 or section 15(d) of the Exchange Act; or
(B) causing any class of equity securities of the issuer which is either listed on a national securities exchange or authorized to be quoted in an inter-dealer quotation system of a registered national securities association to be neither listed on any national securities exchange nor authorized to be quoted on an inter-dealer quotation system of any registered national securities association.
The Offer for the Securities is neither reasonably likely to nor intended to trigger the events listed in Rule 13e-3(a)(3)(ii). As set forth below, each series of Securities was held of record by fewer than 1,200 persons prior to the time of the Offer. Thus, the Offer will not “cause” the Securities to become eligible for termination of registration or suspension of reporting under Rule 13e-3(a)(3)(ii)(A). In addition, the Offer is unlikely to cause either the Series E Depositary Shares or the Series D Depositary Shares to be neither listed on any national securities exchange nor authorized to be quoted on an inter-dealer quotation system of a registered national securities association, pursuant to Rule 13e-3(a)(3)(ii)(B).
Paragraph (a)(3)(ii)(A) of Rule 13e-3. As of May 20, 2019, according to securities position listing reports, there were 60 record holders of the Series E Depositary Shares, and there were 52 record holders of the Series D Depositary Shares. The Company has no reason to believe that the holders of record as of the date of the Offer had materially changed. The number of holders of record for each series of Securities is fewer than 1,200 record holders as described in Rules 12g-4 and 12h-3 under the Exchange Act and as described in Section 15(d) of the Exchange Act, in each case as applicable to banks. Thus, pursuant to Compliance & Disclosure Interpretation 104.01 (“Going Private Transactions by Certain Issuers and Their Affiliates”), the Offer will not cause any series of the Securities to become eligible for termination of registration under Exchange Act Rule 12g-4 or for suspension of reporting obligations under Rule 12h-3 or Section 15(d) of the Exchange Act.
Paragraph (a)(3)(ii)(B) of Rule 13e-3. The Series E Depositary Shares and Series D Depositary Shares are both listed on the New York Stock Exchange (“NYSE”). The Company intends to maintain such listing after completion of the Offer and has structured the Offer so that it is not reasonably likely to result in the delisting of either the Series E Depositary Shares or the Series D Depositary Shares. Section 703.05 of the NYSE Listed Company Manual indicates that it will give consideration to suspension and delisting of a preferred stock if (i) the aggregate market value of publicly-held shares is less than $2,000,000 and (ii) the number of publicly-held shares is less than 100,000.
Pursuant to the terms of the Offer, there is no reasonable likelihood that either the Series E Depositary Shares or the Series D Depositary Shares will be considered for suspension or delisting under NYSE rules. The Company has offered to purchase Securities of both series in an amount such that the aggregate purchase price, plus Accrued Dividends, shall not exceed $75,000,000 (the “Maximum Aggregate Purchase Price”). Furthermore, the Company has stated that it will accept Securities for purchase in accordance with the acceptance priority levels listed in the Offer to Purchase, with the Series E Depositary Shares having priority over the Series D Depositary Shares.
If the total consideration paid for the Series E Depositary Shares were to equal the Maximum Aggregate Purchase Price, the Company would purchase approximately 2,764,467 shares at a total consideration price of $27.13, based on an expected Settlement Date of August 23, 2019. As of the date of the Offer to Purchase, there were 5,000,000 outstanding Series E Depositary Shares publicly-held, and therefore a reduction of 2,764,467 publicly-held shares would result in 2,235,533 publicly-held shares outstanding, far in excess of the NYSE minimum of 100,000 shares. In addition, valued at the market price of $26.76 per share on July 24, 2019, the last trading day prior to the date of the Offer to Purchase, such 2,235,533 shares would have a market value of approximately $59,822,863, again in excess of the NYSE minimum of $2,000,000.
If, on the other hand, no shareholders tender any Series E Depositary Shares and so the total consideration paid for the Series D Depositary Shares were to equal the Maximum Aggregate Purchase Price, the Company would purchase approximately 2,841,985 shares at a total consideration price of $26.39, based on an expected Settlement Date of August 23, 2019. As of the date of the Offer to Purchase, there were 4,600,000 outstanding Series E Depositary Shares publicly-held, and therefore a reduction of 2,841,985 publicly-held shares would result in 1,758,015 publicly-held shares outstanding, far in excess of the NYSE minimum of 100,000 shares. Further, valued at the market price of $26.07 per share on July 24, 2019, the last trading day prior to the date of the Offer to Purchase, such 1,758,015 shares would have a market value of approximately $45,831,451, again in excess of the NYSE minimum of $2,000,000.
As demonstrated above, there is no circumstance wherein the Offer could result in either series of the Securities being considered for suspension or delisting in accordance with the NYSE Listed Company Manual and thus would not satisfy paragraph (a)(3)(ii)(B) of Rule 13e-3.